Literature DB >> 29702748

Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.

Barbara Carey1, Jonathan Lambourne2, Stephen Porter1, Tim Hodgson1.   

Abstract

Chronic mucocutaneous candidiasis (CMC) is a heterogenous group of primary immunodeficiency diseases characterised by susceptibility to chronic or recurrent superficial Candida infection of skin, nails and mucous membranes. Gain-of-function mutations in the STAT1 gene (STAT1-GOF) are the most common genetic aetiology for CMC, and mutation analysis should be considered. These mutations lead to defective responses in Type 1 and Type 17 helper T cells (Th1 and Th17), which, depending on the mutation, also predispose to infection with Staphylococci, Mycobacteria and Herpesviridae. We describe the clinical and genetic findings for three patients with CMC due to gain-of-function mutations in the STAT1 gene.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  Candida; STAT1 transcription factor; antifungal agents; chronic mucocutaneous candidiasis; immunologic deficiency syndromes; interleukin-17; point mutation

Mesh:

Substances:

Year:  2018        PMID: 29702748     DOI: 10.1111/odi.12881

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  7 in total

Review 1.  Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Authors:  Satoshi Okada; Takaki Asano; Kunihiko Moriya; Stephanie Boisson-Dupuis; Masao Kobayashi; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2020-08-27       Impact factor: 8.317

2.  Live Cell Imaging Demonstrates Multiple Routes Toward a STAT1 Gain-of-Function Phenotype.

Authors:  Simone Giovannozzi; Veerle Lemmens; Jelle Hendrix; Rik Gijsbers; Rik Schrijvers
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

3.  Persistence of Clonal Azole-Resistant Isolates of Candida albicans from a Patient with Chronic Mucocutaneous Candidiasis in Colombia.

Authors:  Andrés Ceballos-Garzon; Luz M Wintaco-Martínez; Norida Velez; Catalina Hernandez-Padilla; Alejandro De la Hoz; Sandra Liliana Valderrama-Beltrán; Carlos A Alvarez-Moreno; Patrice Le Pape; Juan David Ramírez; Claudia M Parra-Giraldo
Journal:  J Glob Infect Dis       Date:  2020-02-19

Review 4.  Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation.

Authors:  Ioannis Kienes; Tanja Weidl; Nora Mirza; Mathias Chamaillard; Thomas A Kufer
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

5.  Chronic Mucocutaneous Candidiasis due to Signal Transducer and Activator of Transcription 1 (STAT 1) Mutation in an Indian Patient - A Case Report.

Authors:  Abyramy Balasundaram; Renu George; Aby Abraham; Joy S Michael
Journal:  Indian Dermatol Online J       Date:  2022-01-24

6.  Chronic demodicosis in patients with immune dysregulation: An unexpected infectious manifestation of Signal transducer and activator of transcription (STAT)1 gain-of-function.

Authors:  Oded Shamriz; Atar Lev; Amos J Simon; Ortal Barel; Elisheva Javasky; Sigal Matza-Porges; Adir Shaulov; Zev Davidovics; Ori Toker; Raz Somech; Abraham Zlotogorski; Vered Molho-Pessach; Yuval Tal
Journal:  Clin Exp Immunol       Date:  2021-07-12       Impact factor: 5.732

Review 7.  Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies.

Authors:  Oded Shamriz; Yuval Tal; Aviv Talmon; Amit Nahum
Journal:  Front Immunol       Date:  2020-10-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.